Bristol-Myers

Bristol-Myers and Seattle Genetics move a promising flagship combo into PhIII
Endpoints
Fri, 06/2/17 - 11:16 am
Bristol-Myers
Seattle Genetics
Opdivo
Adcetris
Hodgkin's lymphoma
Bristol-Myers' HIV-1 Drug Approved In Europe
Yahoo/Benzinga
Thu, 07/16/15 - 02:22 pm
Bristol-Myers
HIV-1 Europe
Evotaz
Bristol-Myers rips up its R&D group, adding, eliminating and moving hundreds
Fierce Biotech
Thu, 06/25/15 - 11:20 am
Bristol-Myers
R&D
layoffs